Come up with a name for your new list and we'll add to it:
BeiGene raised a round of funding on May 05, 2014. Investors include
Merck & Co..
BeiGene is a Chinese oncology R&D company focused on discovering, developing and commercializing targeted and immune-oncology therapeutics through a novel translational research platform that combines…